More than 400 Biotechnology Drugs and Vaccines Under Trials
Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics on August 16, 2006
A new report (pdf file) from the Pharmaceutical Research and Manufacturers Association (PhRMA) found 418 medicines and vaccines developed through biotechnology in various stages of development to treat more than 100 diseases. The breakdown:
- 210 medicines to treat cancer
- 50 to treat infectious disease
- 44 to treat autoimmune disorders
- 22 to treat HIV Infection and related-conditions and
- 22 to treat cardiovascular diseases
The report also highlights biotech drugs such as:
- monoclonal antibodies targeting asthma, lupus and various types of cancer
- vaccines designed against AIDS and cancer
- antisense products as potential treatments for cancer and heart disease
- gene therapy testing in cancer and heart disease.
You may download (pdf file) the report here. You may also want to read the report backgrounder on some biotech drugs being developed to treat anemia, rheumatoid arthritis, inflammatory bowel disease, muscular dystrophy, and protate cancer.
[Source: PhRMA]

Tags: biotechnology drugs biotech more vaccines drugs+vaccines biotechnology+drugs more+than
Vote for More than 400 Biotechnology Drugs and Vaccines Under Trials:
|
Rating: 8.88 out of 16 vote(s) cast.
|
Response from:
hasan
(08/13/08 9:46pm)
I need the list of the products.
Response from:
puneet kaushik
(01/09/10 3:44pm)
good attempts, i highly appreciate.
hope for more n more latest researches to be made available.
hope for more n more latest researches to be made available.
Response from:
behiye
(02/21/10 10:35pm)
what is the latest number of this biotecnological drugs?
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells
